"CD55 Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
GPI-linked membrane proteins broadly distributed among hematopoietic and non-hematopoietic cells. CD55 prevents the assembly of C3 CONVERTASE or accelerates the disassembly of preformed convertase, thus blocking the formation of the membrane attack complex.
| Descriptor ID |
D018958
|
| MeSH Number(s) |
D12.776.395.550.448.130 D12.776.543.484.500.130 D12.776.543.550.418.130
|
| Concept/Terms |
CD55 Antigens- CD55 Antigens
- CD55 Antigen
- Complement Decay-Accelerating Factor
- Complement Decay Accelerating Factor
- Decay-Accelerating Factor, Complement
- Antigens, CD55
- Decay-Accelerating Factor
- Decay Accelerating Factor
|
Below are MeSH descriptors whose meaning is more general than "CD55 Antigens".
Below are MeSH descriptors whose meaning is more specific than "CD55 Antigens".
This graph shows the total number of publications written about "CD55 Antigens" by people in this website by year, and whether "CD55 Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "CD55 Antigens" by people in Profiles.
-
IFITM3, TLR3, and CD55 Gene SNPs and Cumulative Genetic Risks for Severe Outcomes in Chinese Patients With H7N9/H1N1pdm09 Influenza. J Infect Dis. 2017 07 01; 216(1):97-104.
-
Overexpression of Human CD55 and CD59 or Treatment with Human CD55 Protects against Renal Ischemia-Reperfusion Injury in Mice. J Immunol. 2017 06 15; 198(12):4837-4845.
-
Expression of a Synthetic Gene of CTDM by Transgenic Animals. Transplant Proc. 2016 May; 48(4):1279-81.
-
Spontaneous abortion is associated with elevated systemic C5a and reduced mRNA of complement inhibitory proteins in placenta. Clin Exp Immunol. 2014 Sep; 177(3):743-9.
-
PI3K/Akt pathway restricts epithelial adhesion of Dr + Escherichia coli by down-regulating the expression of decay accelerating factor. Exp Biol Med (Maywood). 2014 May; 239(5):581-94.
-
Role of transcription factor Sp1 and RNA binding protein HuR in the downregulation of Dr+ Escherichia coli receptor protein decay accelerating factor (DAF or CD55) by nitric oxide. FEBS J. 2013 Feb; 280(3):840-54.
-
Nitric oxide induces segregation of decay accelerating factor (DAF or CD55) from the membrane lipid-rafts and its internalization in human endometrial cells. Cell Biol Int. 2012 Oct 01; 36(10):901-7.
-
Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats. Haematologica. 2009 Jan; 94(1):29-37.
-
IFN-gamma and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production. J Immunol. 2008 May 01; 180(9):5882-9.
-
Epithelial invasion by Escherichia coli bearing Dr fimbriae is controlled by nitric oxide-regulated expression of CD55. Infect Immun. 2004 May; 72(5):2907-14.